​

Funding Round

Series A - Spero Therapeutics

Series A - Spero Therapeutics

Investment Firm

Overview

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Announced Date

Jun 08, 2015

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Lundbeckfonden Ventures

Lundbeckfonden Ventures

Lundbeckfonden Ventures is a debt and early_stage_venture and grant and late_stage_venture and venture firm.

Participant Investors

8

Investor Name
Participant InvestorPartners Innovation Fund
Participant InvestorGlaxoSmithKline
Participant InvestorSR One
Participant InvestorAtlas Venture
Participant InvestorThe Kraft Group

Round Details and Background

Spero Therapeutics raised $30000000 on 2015-06-08 in Series A

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Company Funding History

15

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 08, 2017
Series C - Spero Therapeutics
9-51.7M
Feb 02, 2016
Series B - Spero Therapeutics
8-30.0M
Jun 08, 2015
Series A - Spero Therapeutics
8-30.0M
Apr 09, 2014
Series A - Spero Therapeutics
4-3.0M

Recent Activity

There is no recent news or activity for this profile.